The Problems and Potential of China's Pharmaceutical Industry PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Problems and Potential of China's Pharmaceutical Industry PDF full book. Access full book title The Problems and Potential of China's Pharmaceutical Industry by Roger Bate. Download full books in PDF and EPUB format.

The Problems and Potential of China's Pharmaceutical Industry

The Problems and Potential of China's Pharmaceutical Industry PDF Author: Roger Bate
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Book Description
China's pharmaceutical market has experienced significant growth in recent years, fueled by increasing wealth among its own population as well as accelerating global demand for cheap, effective medicines to treat ailments ranging from high cholesterol to HIV/AIDS. Along with India, China supplies more than 40 percent of the active pharmaceutical ingredients (API) used to make U.S. pharmaceuticals. The current financial crisis, and the limited resources and tighter budgets it has engendered, may accelerate the trend. Yet, China is dogged by a history of poor-quality pharmaceuticals that have killed hundreds and sickened thousands of its own citizens and people across the globe. The government has begun to tighten its laws, but enforcement remains weak, and official obfuscation is rampant. While any retaliatory protectionist measures in the United States would be counterproductive, China and its international partners would gain from improving the frequency and technical sophistication of inspections, the prosecution of perpetrators, and the culture of self-policing within China's pharmaceutical industry.

The Problems and Potential of China's Pharmaceutical Industry

The Problems and Potential of China's Pharmaceutical Industry PDF Author: Roger Bate
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Book Description
China's pharmaceutical market has experienced significant growth in recent years, fueled by increasing wealth among its own population as well as accelerating global demand for cheap, effective medicines to treat ailments ranging from high cholesterol to HIV/AIDS. Along with India, China supplies more than 40 percent of the active pharmaceutical ingredients (API) used to make U.S. pharmaceuticals. The current financial crisis, and the limited resources and tighter budgets it has engendered, may accelerate the trend. Yet, China is dogged by a history of poor-quality pharmaceuticals that have killed hundreds and sickened thousands of its own citizens and people across the globe. The government has begun to tighten its laws, but enforcement remains weak, and official obfuscation is rampant. While any retaliatory protectionist measures in the United States would be counterproductive, China and its international partners would gain from improving the frequency and technical sophistication of inspections, the prosecution of perpetrators, and the culture of self-policing within China's pharmaceutical industry.

China's Healthcare System and Reform

China's Healthcare System and Reform PDF Author: Lawton Robert Burns
Publisher: Cambridge University Press
ISBN: 1316738396
Category : Business & Economics
Languages : en
Pages : 744

Book Description
This volume provides a comprehensive review of China's healthcare system and policy reforms in the context of the global economy. Following a value-chain framework, the 16 chapters cover the payers, the providers, and the producers (manufacturers) in China's system. It also provides a detailed analysis of the historical development of China's healthcare system, the current state of its broad reforms, and the uneasy balance between China's market-driven approach and governmental regulation. Most importantly, it devotes considerable attention to the major problems confronting China, including chronic illness, public health, and long-term care and economic security for the elderly. Burns and Liu have assembled the latest research from leading health economists and political scientists, as well as senior public health officials and corporate executives, making this book an essential read for industry professionals, policymakers, researchers, and students studying comparative health systems across the world.

China Medical and Pharmaceutical Industry Business Intelligence Report Volume 1 Strategic Information, Regulations, Contacts

China Medical and Pharmaceutical Industry Business Intelligence Report Volume 1 Strategic Information, Regulations, Contacts PDF Author: IBP, Inc
Publisher: Lulu.com
ISBN: 1433061309
Category : Business & Economics
Languages : en
Pages : 327

Book Description
2011 Updated Reprint. Updated Annually. China Pharmaceutical Chemicals Producers Directory

The Chemical and Pharmaceutical Industry in China

The Chemical and Pharmaceutical Industry in China PDF Author: G. Festel
Publisher: Springer Science & Business Media
ISBN: 3540265619
Category : Business & Economics
Languages : en
Pages : 295

Book Description
A detailed examination of China’s increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.

Biopharma in China

Biopharma in China PDF Author: Sven Agten
Publisher: Springer Nature
ISBN: 9819714710
Category :
Languages : en
Pages : 157

Book Description


The Commercialization of Pharmaceutical Patents in China

The Commercialization of Pharmaceutical Patents in China PDF Author: James Hou
Publisher: Edward Elgar Publishing
ISBN: 9781789908220
Category :
Languages : en
Pages : 352

Book Description
Presenting detailed analysis of the industrialization and commercialization of pharmaceutical patents in China, this timely book explores a range of related topics including a comparison of the ideal and existing state of the pharmaceutical market and patent industrialization. It argues that the core purpose of the industrialization of pharmaceutical patents is to promote the development of the local pharmaceutical industry whist also protecting society's right to safe and effective medication. Chapters examine the special application issues of patent law in relation to the field of pharmaceuticals, compare the Chinese and American legal systems and their approach to pharmaceutical patents, and provide in depth political and legal analysis of the industry. James Hou suggests methods by which the Chinese legal system can seek to improve its governance of pharmaceutical patents and balance the conflicts of interest arising between new drug developers, established drug manufacturers and the end users. Featuring comprehensive coverage of patents in the Chinese pharmaceutical industry, this book will be a key resource for scholars and students of commercial, pharmaceutical and intellectual property law, whilst also being of interest to industry talents discovering the potential of their own innovations.

China Rx

China Rx PDF Author: Rosemary Gibson
Publisher: Prometheus Books
ISBN: 1633883817
Category : Business & Economics
Languages : en
Pages : 306

Book Description
Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers. Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This is a disturbing, well-researched book and a wake-up call for improving the current system of drug supply and manufacturing.

Approaching China's Pharmaceutical Market

Approaching China's Pharmaceutical Market PDF Author: Ming Q. Lu
Publisher:
ISBN: 9783319155777
Category :
Languages : en
Pages :

Book Description
This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)--including its regulations and registration procedures--and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China's pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues.

China Rx

China Rx PDF Author: Rosemary Gibson
Publisher:
ISBN: 9781633886414
Category :
Languages : en
Pages : 314

Book Description
With a New Epilogue by co-author Rosemary Gibson. Millions of Americans are taking prescription drugs made in China and don't know it--and pharmaceutical companies are not eager to tell them. This is a disturbing, well-researched wake-up call for improving the current system of drug supply and manufacturing.Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This probing book examines the implications of our reliance on China on the quality and availability of vital medicines.

Learning from SARS

Learning from SARS PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309182158
Category : Medical
Languages : en
Pages : 376

Book Description
The emergence of severe acute respiratory syndrome (SARS) in late 2002 and 2003 challenged the global public health community to confront a novel epidemic that spread rapidly from its origins in southern China until it had reached more than 25 other countries within a matter of months. In addition to the number of patients infected with the SARS virus, the disease had profound economic and political repercussions in many of the affected regions. Recent reports of isolated new SARS cases and a fear that the disease could reemerge and spread have put public health officials on high alert for any indications of possible new outbreaks. This report examines the response to SARS by public health systems in individual countries, the biology of the SARS coronavirus and related coronaviruses in animals, the economic and political fallout of the SARS epidemic, quarantine law and other public health measures that apply to combating infectious diseases, and the role of international organizations and scientific cooperation in halting the spread of SARS. The report provides an illuminating survey of findings from the epidemic, along with an assessment of what might be needed in order to contain any future outbreaks of SARS or other emerging infections.